OA10395A - Utilisation du triacétate de glycéryle pour le traitement d'onychomycoses - Google Patents

Utilisation du triacétate de glycéryle pour le traitement d'onychomycoses Download PDF

Info

Publication number
OA10395A
OA10395A OA60953A OA60953A OA10395A OA 10395 A OA10395 A OA 10395A OA 60953 A OA60953 A OA 60953A OA 60953 A OA60953 A OA 60953A OA 10395 A OA10395 A OA 10395A
Authority
OA
OAPI
Prior art keywords
nail polish
formula
nail
hydroxy
pyridone
Prior art date
Application number
OA60953A
Other languages
English (en)
French (fr)
Inventor
Manfred Bohn
Karl Kraemer
Astrid Markus
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of OA10395A publication Critical patent/OA10395A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q3/00—Manicure or pedicure preparations
    • A61Q3/02—Nail coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
OA60953A 1995-05-18 1997-01-17 Utilisation du triacétate de glycéryle pour le traitement d'onychomycoses OA10395A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19518262A DE19518262A1 (de) 1995-05-18 1995-05-18 Die Verwendung von Glyceryltriacetat zur Behandlung von Onychomykosen

Publications (1)

Publication Number Publication Date
OA10395A true OA10395A (fr) 2001-12-04

Family

ID=7762250

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60953A OA10395A (fr) 1995-05-18 1997-01-17 Utilisation du triacétate de glycéryle pour le traitement d'onychomycoses

Country Status (32)

Country Link
US (1) US6162420A (es)
EP (1) EP0777457B1 (es)
JP (1) JP3653098B2 (es)
KR (1) KR100442161B1 (es)
CN (1) CN1193730C (es)
AR (1) AR002743A1 (es)
AT (1) ATE221763T1 (es)
AU (1) AU699323B2 (es)
BG (1) BG63589B1 (es)
BR (1) BR9606662B1 (es)
CA (1) CA2195455A1 (es)
CY (1) CY2386B1 (es)
CZ (1) CZ290526B6 (es)
DE (2) DE19518262A1 (es)
DK (1) DK0777457T3 (es)
ES (1) ES2180774T3 (es)
HK (1) HK1011936A1 (es)
HU (1) HU226246B1 (es)
IL (1) IL118289A (es)
MA (1) MA23870A1 (es)
MX (1) MX9700470A (es)
MY (1) MY124480A (es)
NO (1) NO312395B1 (es)
NZ (1) NZ307555A (es)
OA (1) OA10395A (es)
PL (1) PL184648B1 (es)
PT (1) PT777457E (es)
RO (1) RO120039B1 (es)
TW (1) TW496738B (es)
UA (1) UA44280C2 (es)
WO (1) WO1996036311A1 (es)
ZA (1) ZA963935B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19643831A1 (de) 1996-10-30 1998-05-07 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von schwer therapierbaren Schleimhauterkrankungen
DE19639817A1 (de) 1996-09-27 1998-04-02 Hoechst Ag Verwendung von 1-Hydroxy-2-pyridonen zur Behandlung von Hautinfektionen
DE19639816A1 (de) * 1996-09-27 1998-04-02 Hoechst Ag Antimykotische Mittel mit hoher Wirkstofffreisetzung
US20040039030A1 (en) * 1996-09-27 2004-02-26 Hoechst Akeengesellschaft Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
RO118174B1 (ro) * 1997-08-21 2003-03-28 Aventis Pharma Deutschland Gmbh Lac de unghii şi utilizarea acestuia
US6401724B1 (en) * 1999-10-11 2002-06-11 Par Pharmaceuticals Incorporated Method of applying a cosmetic nail lacquer or polish to a nail
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US6664292B2 (en) * 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US7135194B2 (en) * 2002-09-27 2006-11-14 Birnbaum Jay E Subunguicide, and method for treating onychomycosis
US8404751B2 (en) * 2002-09-27 2013-03-26 Hallux, Inc. Subunguicide, and method for treating onychomycosis
US9078864B2 (en) 2008-01-08 2015-07-14 Akthelia Pharmaceuticals Agonists for antimicrobial peptide systems
DE102008041049A1 (de) * 2008-08-06 2010-02-11 Sonja Spohler Verwendung einer antimykotischen Zusammensetzung zur topischen Behandlung von Pilzerkrankungen von Fuß- und Fingernägeln
CN103110566A (zh) * 2013-01-31 2013-05-22 巫国谊 一种纠正婴幼儿吮吸手指不良习惯的外用涂剂
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP2016514024A (ja) 2013-03-14 2016-05-19 ハラックス，インコーポレイテッド 爪部の感染症、疾患または障害の治療方法
CN110693754B (zh) * 2019-11-16 2022-08-23 烟台东方化学有限公司 一种抗菌消炎的吡啶酮组合物及包含其的化妆品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3544983A1 (de) * 1985-12-19 1987-06-25 Hoechst Ag Antimykotisch wirksamer nagellack
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
CA2008775C (en) * 1989-02-24 1998-12-22 Alberto Ferro Nail lacquer
US5066484A (en) * 1990-04-30 1991-11-19 Revlon, Inc. Nail enamels containing glyceryl, glycol or citrate esters
DE4212105A1 (de) * 1992-04-10 1993-10-14 Roehm Pharma Gmbh Nagellack zur Behandlung von Onychomykosen
FR2697749B1 (fr) * 1992-11-12 1995-01-13 Oreal Composition cosmétique filmogène à base d'un copolymère chloré greffé résultant du greffage d'une polyoléfine chlorée et de monomères insaturés du type acrylique, styrénique et/ou vinylique.
FR2718349B1 (fr) * 1994-04-07 1996-05-31 Oreal Compositions cosmétiques à appliquer sur l'ongle.

Also Published As

Publication number Publication date
EP0777457B1 (de) 2002-08-07
KR970704413A (ko) 1997-09-06
WO1996036311A1 (de) 1996-11-21
BG101138A (en) 1998-03-31
BR9606662B1 (pt) 2010-08-10
DE19518262A1 (de) 1996-11-21
JPH10503219A (ja) 1998-03-24
MA23870A1 (fr) 1996-12-31
JP3653098B2 (ja) 2005-05-25
CA2195455A1 (en) 1996-11-21
CZ290526B6 (cs) 2002-08-14
BG63589B1 (bg) 2002-06-28
CN1156958A (zh) 1997-08-13
ATE221763T1 (de) 2002-08-15
AU699323B2 (en) 1998-12-03
PL184648B1 (pl) 2002-11-29
HUP9700153A3 (en) 1999-01-28
ES2180774T3 (es) 2003-02-16
MY124480A (en) 2006-06-30
DE59609538D1 (de) 2002-09-12
AU5693696A (en) 1996-11-29
CN1193730C (zh) 2005-03-23
NO970198D0 (no) 1997-01-16
BR9606662A (pt) 1997-10-28
NZ307555A (en) 1998-01-26
PL318312A1 (en) 1997-06-09
HU9700153D0 (en) 1997-03-28
MX9700470A (es) 1998-05-31
UA44280C2 (uk) 2002-02-15
EP0777457A1 (de) 1997-06-11
NO970198L (no) 1997-01-16
TW496738B (en) 2002-08-01
RO120039B1 (ro) 2005-08-30
IL118289A0 (en) 1996-09-12
US6162420A (en) 2000-12-19
HU226246B1 (en) 2008-07-28
HUP9700153A2 (hu) 1998-03-02
AR002743A1 (es) 1998-04-29
CZ14197A3 (en) 1997-04-16
PT777457E (pt) 2002-12-31
IL118289A (en) 2000-08-31
NO312395B1 (no) 2002-05-06
DK0777457T3 (da) 2002-11-11
CY2386B1 (en) 2004-09-10
ZA963935B (en) 1996-11-25
KR100442161B1 (ko) 2004-10-02
HK1011936A1 (en) 1999-07-23

Similar Documents

Publication Publication Date Title
OA10395A (fr) Utilisation du triacétate de glycéryle pour le traitement d'onychomycoses
CA2005695C (fr) Utilisation de derives salicyles pour le traitement du vieillissement de la peau
EP0793476B1 (fr) Utilisation de la mangiférine ou ses dérivés pour une application cosmétique
US4957730A (en) Antimycotic nail varnish
EP0971687B1 (fr) Solutions aqueuses de derives d'acide salicylique
EP1172091B1 (fr) Utilisation du 4',5,7-trihydroxyflavylium pour colorer la peau
CA1166162A (fr) Utilisation de l'huile de cafe comme agent filtrant solaire, composition et procede de protection la mettant en oeuvre
EP0390682A1 (fr) Compositions cosmétiques et pharmaceutiques contenant des dérivés hydrophiles du benzylidène camphre et nouveaux dérivés sulfonés hydrophilesdu benzylidène camphre
FR2811554A1 (fr) Composition comprenant au moins un filtre uv et un sel de flavylium non substitue en position 3 pour la coloration de la peau et utilisations
EP1172090B1 (fr) Compositions pour la coloration de la peau comprenant la dihydroxyacétone et un sel de flavylium non substitué en position 3
EP0948313B1 (fr) Utilisation d'un extrait de resine d'okoume, dans les domaines cosmetique et pharmaceutique, notamment dermatologiques
FR2755015A1 (fr) Utilisation d'un extrait flavonoidique de ginkgo biloba substantiellement depourvu de terpenes, dans le domaine buccodentaire, et composition contenant un tel extrait
CA2462579A1 (fr) Utilisation du tazarotene pour la preparation d'un vernis a ongles pour le traitement et/ou la prevention du psoriasis et un vernis a ongles le contenant
EP0946140B1 (fr) Utilisation d'un extrait de cordia dichotoma
EP1591101A1 (fr) Dissolvant gel sans acetone
FR2787711A1 (fr) Composition cosmetique a activite depigmentante et son utilisation
FR2714054A1 (fr) Procédé de fabrication de la 4-hydroxy-5-méthyl-3[2H]-furanone et utilisations de cette dernière.
WO1996002226A1 (fr) Nouveau produit de combinaison comprenant un agent antifongique et du crotamiton comme potentialisateur de l'activite de l'agent antifongique, et compositions dermatologiques et/ou cosmetiques le comprenant
CA2533720A1 (fr) Vernis a ongles a action antimycosique
FR3132433A1 (fr) Composition cosmétique comprenant un ou plusieurs tensioactifs anioniques particuliers, un ou plusieurs hydroxyhydrocarbyl (poly)glycosides et un ou plusieurs acides carboxyliques spécifiques
FR2834454A1 (fr) Compositions pour la coloration de la peau comprenant un extrait de sorgho et utilisations
FR2735695A1 (fr) Compositions cosmetiques ou pharmaceutiques contenant a titre de principe actif, de la mangiferine ou ses derives